Latest news with #EuropeanPennyStocks
Yahoo
28-05-2025
- Business
- Yahoo
European Penny Stocks Under €70M Market Cap To Watch
European markets have recently faced a downturn, with major indices such as the STOXX Europe 600 Index experiencing declines amid heightened trade tensions following proposed tariffs by the U.S. administration. In times of market volatility, investors often look beyond large-cap stocks to explore opportunities in smaller companies that might offer untapped potential. While "penny stocks" may sound like a throwback to earlier trading days, they represent an intriguing investment area where smaller or newer companies can present significant growth prospects when backed by solid financials. Name Share Price Market Cap Financial Health Rating Bredband2 i Skandinavien (OM:BRE2) SEK2.295 SEK2.2B ★★★★☆☆ Transferator (NGM:TRAN A) SEK2.16 SEK205.35M ★★★★★☆ Angler Gaming (NGM:ANGL) SEK3.79 SEK284.19M ★★★★★★ Hifab Group (OM:HIFA B) SEK3.54 SEK215.37M ★★★★★★ IMS (WSE:IMS) PLN4.09 PLN138.63M ★★★★☆☆ Cellularline (BIT:CELL) €2.91 €61.38M ★★★★★☆ Netgem (ENXTPA:ALNTG) €0.946 €31.68M ★★★★★★ Fondia Oyj (HLSE:FONDIA) €4.69 €17.54M ★★★★★★ Mistral Iberia Real Estate SOCIMI (BME:YMIB) €1.01 €22M ★★★★★☆ Deceuninck (ENXTBR:DECB) €2.15 €296.84M ★★★★★★ Click here to see the full list of 446 stocks from our European Penny Stocks screener. Let's dive into some prime choices out of the screener. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Equita Group S.p.A. operates in sales and trading, investment banking, and alternative asset management services for investors, financial institutions, corporates, and entrepreneurs both in Italy and internationally, with a market cap of €226.36 million. Operations: Equita Group S.p.A. has not reported any specific revenue segments. Market Cap: €226.36M Equita Group S.p.A., with a market cap of €226.36 million, presents a mixed picture for investors interested in penny stocks. The company is debt-free, which reduces financial risk, and its short-term assets comfortably cover both short- and long-term liabilities. However, its dividend yield is not well-supported by earnings or free cash flows, raising sustainability concerns. Despite stable weekly volatility and a price-to-earnings ratio below the Italian market average, earnings growth has been modest at 2% over the past year and has not kept pace with industry standards. Recent quarterly net income rose to €4.68 million from €3.06 million last year. Click to explore a detailed breakdown of our findings in Equita Group's financial health report. Explore Equita Group's analyst forecasts in our growth report. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: WithSecure Oyj operates in the corporate security business globally and has a market cap of approximately €180.77 million. Operations: The company's revenue segments include Elements Company generating €105.66 million and Cloud Protection for Salesforce contributing €10.72 million. Market Cap: €180.77M WithSecure Oyj, with a market cap of €180.77 million, offers potential for investors in the penny stock arena despite current unprofitability and increasing losses over five years. The company has robust short-term assets (€86.6M) that exceed both short- (€71.3M) and long-term liabilities (€41.8M). Recent strategic partnerships, like the one with Stellar Cyber, aim to enhance threat detection capabilities, potentially driving future growth. Although trading slightly below fair value estimates and maintaining stable weekly volatility, its management team is relatively experienced but faces challenges in improving profitability metrics such as return on equity (-13.24%). Jump into the full analysis health report here for a deeper understanding of WithSecure Oyj. Evaluate WithSecure Oyj's prospects by accessing our earnings growth report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Hamlet BioPharma AB (publ) is a Swedish company focused on developing drugs for cancer treatment and prevention, with a market cap of SEK739.17 million. Operations: Hamlet BioPharma AB does not have any reported revenue segments at this time. Market Cap: SEK739.17M Hamlet BioPharma AB, with a market cap of SEK739.17 million, remains pre-revenue and unprofitable but offers potential through its innovative drug development pipeline. The company's lead candidate, Alpha1H, shows promise in treating bladder cancer by targeting tumor cells' endoplasmic reticulum to induce cell death while sparing healthy tissue. This unique mechanism may provide a competitive edge and enhance investor confidence. Despite stable weekly volatility (7%) and no debt or long-term liabilities, Hamlet faces financial challenges with less than a year of cash runway based on current free cash flow trends and increasing losses over five years. Click here to discover the nuances of Hamlet BioPharma with our detailed analytical financial health report. Review our historical performance report to gain insights into Hamlet BioPharma's track record. Click this link to deep-dive into the 446 companies within our European Penny Stocks screener. Seeking Other Investments? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BIT:EQUI HLSE:WITH and NGM:HAMLET B. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
28-05-2025
- Business
- Yahoo
Patria Bank And 2 Other Promising European Penny Stocks
As European markets experience a boost in sentiment following the de-escalation of trade tensions between the U.S. and China, investors are increasingly looking for opportunities within this landscape. Penny stocks, despite their somewhat outdated name, continue to represent a compelling area for those interested in smaller or newer companies that might offer growth potential at lower price points. By focusing on stocks with strong financial foundations and solid fundamentals, investors can uncover hidden gems that may provide both stability and potential upside in today's market conditions. Name Share Price Market Cap Financial Health Rating Bredband2 i Skandinavien (OM:BRE2) SEK2.29 SEK2.19B ★★★★☆☆ Transferator (NGM:TRAN A) SEK2.59 SEK237.32M ★★★★★☆ Angler Gaming (NGM:ANGL) SEK3.58 SEK268.45M ★★★★★★ Hifab Group (OM:HIFA B) SEK3.70 SEK225.1M ★★★★★★ IMS (WSE:IMS) PLN3.69 PLN125.07M ★★★★☆☆ Cellularline (BIT:CELL) €2.59 €54.63M ★★★★★☆ Netgem (ENXTPA:ALNTG) €0.986 €33.02M ★★★★★★ Fondia Oyj (HLSE:FONDIA) €4.75 €17.76M ★★★★★★ Mistral Iberia Real Estate SOCIMI (BME:YMIB) €1.01 €22M ★★★★★☆ Deceuninck (ENXTBR:DECB) €2.16 €298.22M ★★★★★★ Click here to see the full list of 440 stocks from our European Penny Stocks screener. Let's take a closer look at a couple of our picks from the screened companies. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Patria Bank SA is a credit institution offering banking and financial services to individuals, SMEs, agribusinesses, and corporate clients in Romania with a market cap of RON272.14 million. Operations: Patria Bank SA does not report specific revenue segments. Market Cap: RON272.14M Patria Bank SA has shown significant earnings growth, with a 39.7% increase over the past year, outpacing the industry average. Its net profit margins have improved to 18.4%, and it maintains high-quality earnings. The bank's funding is primarily low-risk due to customer deposits, and its loans-to-deposits ratio of 66% is considered appropriate. Despite a high level of bad loans at 5.1%, its allowance for these is low at 95%. Recent earnings reports show continued growth in net income and interest income, reflecting stability in financial performance amidst market volatility. Click here to discover the nuances of Patria Bank with our detailed analytical financial health report. Explore Patria Bank's analyst forecasts in our growth report. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Turbomecanica SA is a company that manufactures and sells engines, mechanical assemblies, and equipment for aircraft and helicopters across Europe and Asia, with a market cap of RON150.36 million. Operations: The company's revenue is primarily derived from the repairs of engines, which account for RON99.56 million, followed by the manufacturing of aircraft parts at RON31.43 million. Market Cap: RON150.36M Turbomecanica SA has demonstrated robust earnings growth, with a 45% increase over the past year, surpassing the Aerospace & Defense industry average. The company's net profit margins improved to 11.5%, while its price-to-earnings ratio of 9.3x suggests it might be undervalued compared to the broader Romanian market. Turbomecanica's short-term assets comfortably cover both its short and long-term liabilities, indicating financial stability. However, while debt levels have risen slightly over five years, they remain well-managed with operating cash flow covering debt obligations effectively. Despite a stable dividend yield of 5.99%, it's not fully supported by free cash flows. Get an in-depth perspective on Turbomecanica's performance by reading our balance sheet health report here. Explore historical data to track Turbomecanica's performance over time in our past results report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Kerlink SA offers network infrastructure solutions for the Internet of Things (IoT) to operators, businesses, and utilities across various regions including Europe, the Middle East and Africa, the Asia-Pacific, and the Americas, with a market cap of €5.87 million. Operations: The company's revenue is divided into two main segments: Private Networks (Including Reference Design) generating €10.92 million and Historic and Alternative Telecom Operators contributing €0.75 million. Market Cap: €5.87M Kerlink SA, with a market cap of €5.87 million, operates in the IoT network infrastructure space and recently reported full-year sales of €11.67 million, down from the previous year. Despite being unprofitable with a net loss of €3.77 million, Kerlink has managed to reduce its losses over five years by 15% annually and maintains a positive free cash flow that supports a cash runway exceeding three years. The company's short-term assets exceed both short- and long-term liabilities, indicating some financial resilience despite high debt levels with a net debt to equity ratio at 177.9%. Jump into the full analysis health report here for a deeper understanding of Kerlink. Examine Kerlink's earnings growth report to understand how analysts expect it to perform. Click through to start exploring the rest of the 437 European Penny Stocks now. Seeking Other Investments? The end of cancer? These 23 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BVB:PBK BVB:TBM and ENXTPA:ALKLK. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
21-05-2025
- Business
- Yahoo
European Penny Stocks: 3 Picks With Market Caps Under €30M
As European markets experience a boost in sentiment following the easing of trade tensions between the U.S. and China, investors are increasingly looking for opportunities beyond traditional blue-chip stocks. Penny stocks, though often considered a term from the past, continue to offer intriguing prospects for those interested in smaller or newer companies. These stocks can present significant growth potential when backed by strong financials and solid fundamentals, making them an attractive option for investors seeking value in today's market landscape. Name Share Price Market Cap Financial Health Rating Bredband2 i Skandinavien (OM:BRE2) SEK2.29 SEK2.19B ★★★★☆☆ KebNi (OM:KEBNI B) SEK1.72 SEK466.39M ★★★★★★ Transferator (NGM:TRAN A) SEK2.74 SEK246.03M ★★★★★☆ Angler Gaming (NGM:ANGL) SEK3.72 SEK278.94M ★★★★★★ Hifab Group (OM:HIFA B) SEK3.50 SEK212.94M ★★★★★★ IMS (WSE:IMS) PLN3.75 PLN127.1M ★★★★☆☆ Cellularline (BIT:CELL) €2.67 €56.31M ★★★★★☆ Netgem (ENXTPA:ALNTG) €0.97 €32.48M ★★★★★★ Fondia Oyj (HLSE:FONDIA) €4.74 €17.72M ★★★★★★ Deceuninck (ENXTBR:DECB) €2.175 €300.29M ★★★★★★ Click here to see the full list of 446 stocks from our European Penny Stocks screener. Let's uncover some gems from our specialized screener. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Kamux Oyj operates in the wholesale and retail used car market across Finland, Sweden, and Germany, with a market capitalization of €85.73 million. Operations: Kamux Oyj's operations span the wholesale and retail used car market in Finland, Sweden, and Germany. Market Cap: €85.73M Kamux Oyj, with a market cap of €85.73 million, operates in the used car market across Finland, Sweden, and Germany. Despite trading at 42.5% below its estimated fair value and having short-term assets exceeding liabilities, it remains unprofitable with a net loss of €4 million in Q1 2025. The company's dividend yield is unsustainable by earnings, and interest payments are not well covered by EBIT. Recent expansions include new showrooms in Germany and Finland to support its omnichannel strategy. Management changes are underway with a new CFO joining soon to strengthen financial oversight amidst operational challenges. Click here and access our complete financial health analysis report to understand the dynamics of Kamux Oyj. Gain insights into Kamux Oyj's future direction by reviewing our growth report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Spinnova Oyj is involved in the production and sale of natural fiber materials both in Finland and internationally, with a market cap of €23.90 million. Operations: The company's revenue is primarily derived from its textile manufacturing segment, amounting to €0.76 million. Market Cap: €23.9M Spinnova Oyj, with a market cap of €23.90 million, is pre-revenue, generating only €0.76 million from its textile manufacturing segment. Despite having more cash than debt and short-term assets exceeding liabilities, the company remains unprofitable with a negative return on equity of -23.65%. Recent management changes include new roles for key executives to align with development goals, while strategic partnerships face uncertainty as Suzano Plc decided not to invest further in their joint venture. Spinnova's board and management team are relatively inexperienced but are conducting a strategic review to reassess future directions and financial targets. Click here to discover the nuances of Spinnova Oyj with our detailed analytical financial health report. Explore Spinnova Oyj's analyst forecasts in our growth report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Binero Group AB (publ) offers cloud and digital infrastructure services to companies and organizations in Sweden, with a market cap of SEK316.18 million. Operations: The company's revenue of SEK416.38 million is derived from its Internet Software & Services segment. Market Cap: SEK316.18M Binero Group AB, with a market cap of SEK316.18 million, reported revenue of SEK417.2 million for 2024 and achieved profitability with a net income of SEK12.9 million, reversing a prior loss. The company has demonstrated strong earnings growth over the past five years and its debt is well-covered by operating cash flow at 52%. While Binero's board lacks experience with an average tenure of 1.3 years, its management team is seasoned at 2.8 years on average. Despite stable weekly volatility, short-term assets do not fully cover liabilities, posing potential liquidity concerns in the near term. Click to explore a detailed breakdown of our findings in Binero Group's financial health report. Evaluate Binero Group's prospects by accessing our earnings growth report. Reveal the 446 hidden gems among our European Penny Stocks screener with a single click here. Interested In Other Possibilities? The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 27 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include HLSE:KAMUX HLSE:SPINN and OM:BINERO. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
16-05-2025
- Business
- Yahoo
Discovering 3 European Penny Stocks With Market Caps Under €400M
As European markets experience a mix of gains and losses, the pan-European STOXX Europe 600 Index has risen for the fourth consecutive week, driven by hopes of easing trade tensions. In this context, investors may find opportunities in penny stocks—an investment area that, despite its old-fashioned name, remains relevant today. Penny stocks often represent smaller or newer companies with potential for growth when backed by strong financials. Name Share Price Market Cap Financial Health Rating Bredband2 i Skandinavien (OM:BRE2) SEK2.295 SEK2.2B ★★★★☆☆ Transferator (NGM:TRAN A) SEK2.95 SEK285.45M ★★★★★☆ Angler Gaming (NGM:ANGL) SEK3.71 SEK278.19M ★★★★★★ Hifab Group (OM:HIFA B) SEK3.46 SEK210.5M ★★★★★★ Tesgas (WSE:TSG) PLN2.46 PLN27.92M ★★★★★☆ IMS (WSE:IMS) PLN3.70 PLN125.41M ★★★★☆☆ Cellularline (BIT:CELL) €2.64 €55.68M ★★★★★☆ Netgem (ENXTPA:ALNTG) €0.99 €33.15M ★★★★★★ Fondia Oyj (HLSE:FONDIA) €4.60 €17.2M ★★★★★★ Deceuninck (ENXTBR:DECB) €2.22 €306.5M ★★★★★★ Click here to see the full list of 442 stocks from our European Penny Stocks screener. We'll examine a selection from our screener results. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: IRCE S.p.A. manufactures and sells winding wires and electrical cables in Italy, the rest of the European Union, and internationally, with a market cap of €55.02 million. Operations: The company's revenue is derived from two main segments: Winding Wires, generating €319.29 million, and Cables, contributing €78.36 million. Market Cap: €55.02M IRCE S.p.A., with a market cap of €55.02 million, operates in the winding wires and cables segments, generating substantial revenues of €319.29 million and €78.36 million respectively. Despite a recent decline in net income to €6.9 million for 2024, the company maintains strong financial health with short-term assets exceeding both short- and long-term liabilities significantly. The debt is well-covered by operating cash flow, and interest payments are comfortably managed by EBIT at 6.8 times coverage. Trading at a low price-to-earnings ratio of 8x compared to the Italian market average of 15.5x suggests good relative value for investors interested in penny stocks within Europe's electrical industry landscape. Unlock comprehensive insights into our analysis of IRCE stock in this financial health report. Examine IRCE's earnings growth report to understand how analysts expect it to perform. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Catenon, S.A. is a technology-based company that offers recruitment services both in Spain and internationally, with a market cap of €20.28 million. Operations: The company's revenue is generated from the application of new IT and communication technologies, amounting to €12.03 million. Market Cap: €20.28M Catenon, S.A., with a market cap of €20.28 million, has transitioned to profitability over the past year, reporting net income of €0.15 million for 2024 despite a decline in sales to €0.32 million. The company's debt is well-managed, with operating cash flow covering 64.8% of its debt and interest payments comfortably covered by EBIT at 30.9 times coverage. Although the share price remains highly volatile and Return on Equity is low at 4.8%, Catenon's short-term assets significantly exceed both short- and long-term liabilities, reflecting solid financial stability for this penny stock in Europe's tech sector. Get an in-depth perspective on Catenon's performance by reading our balance sheet health report here. Assess Catenon's previous results with our detailed historical performance reports. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: ForFarmers N.V. operates as a provider of feed solutions for both conventional and organic livestock farming across several countries including the Netherlands, the United Kingdom, Germany, Poland, Belgium, and internationally, with a market cap of €381.33 million. Operations: The company generates €2.75 billion in revenue from its food processing segment. Market Cap: €381.33M ForFarmers N.V., with a market cap of €381.33 million, is trading significantly below its estimated fair value and has stabilized its financial position with short-term assets covering both short- and long-term liabilities. The company recently returned to profitability, reporting net income of €31.4 million for 2024, although earnings have been impacted by large one-off items. Despite an unstable dividend history, the recent announcement of a €0.20 per share dividend indicates potential shareholder returns. The board's share repurchase program further suggests confidence in the company's valuation amidst a backdrop of increased debt over the past five years. Dive into the specifics of ForFarmers here with our thorough balance sheet health report. Learn about ForFarmers' future growth trajectory here. Investigate our full lineup of 442 European Penny Stocks right here. Ready For A Different Approach? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BIT:IRC BME:COM and ENXTAM:FFARM. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
15-05-2025
- Business
- Yahoo
3 European Penny Stocks With A Market Cap Of €20M
As European markets continue to navigate a landscape marked by mixed performances and hopes for easing trade tensions, investors are increasingly seeking opportunities in less conventional areas. Penny stocks, although an outdated term, highlight smaller or newer companies that can offer significant potential at lower price points. By focusing on those with strong financials and solid fundamentals, investors may uncover hidden gems with the promise of growth and stability amidst current market conditions. Name Share Price Market Cap Financial Health Rating Bredband2 i Skandinavien (OM:BRE2) SEK2.285 SEK2.19B ★★★★☆☆ Transferator (NGM:TRAN A) SEK3.13 SEK300.72M ★★★★★☆ Angler Gaming (NGM:ANGL) SEK3.80 SEK284.94M ★★★★★☆ Hifab Group (OM:HIFA B) SEK3.46 SEK210.5M ★★★★★★ IMS (WSE:IMS) PLN3.71 PLN125.75M ★★★★☆☆ AMSC (OB:AMSC) NOK1.464 NOK105.21M ★★★★★★ Cellularline (BIT:CELL) €2.65 €55.89M ★★★★★☆ Netgem (ENXTPA:ALNTG) €0.98 €32.82M ★★★★★★ Fondia Oyj (HLSE:FONDIA) €4.63 €17.31M ★★★★★★ Deceuninck (ENXTBR:DECB) €2.23 €307.88M ★★★★★★ Click here to see the full list of 449 stocks from our European Penny Stocks screener. Below we spotlight a couple of our favorites from our exclusive screener. Simply Wall St Financial Health Rating: ★★★★★★ Overview: DigiTouch S.p.A. offers digital marketing and transformation services in Italy, with a market cap of €24.18 million. Operations: The company generates revenue through three main segments: Technology Services (€24.13 million), Marketing Services (€11.49 million), and E-Commerce Services (€3.24 million). Market Cap: €24.18M DigiTouch S.p.A., with a market cap of €24.18 million, operates in digital marketing and transformation services, generating revenues from technology (€24.13M), marketing (€11.49M), and e-commerce services (€3.24M). Despite facing a slight decline in sales from €44.11 million to €40.01 million over the past year, the company maintains stable financial health with short-term assets exceeding liabilities and satisfactory net debt to equity ratio at 37.5%. Earnings growth is forecasted at 22.59% annually, supported by an experienced management team and board of directors while offering dividends of €0.0300 per share payable June 2025. Click to explore a detailed breakdown of our findings in DigiTouch's financial health report. Understand DigiTouch's earnings outlook by examining our growth report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: ATEME SA, along with its subsidiaries, is involved in the production and sales of electronic and computer devices and instruments globally, with a market cap of €48.49 million. Operations: The company generates revenue from the marketing of professional compression and video broadcasting solutions, amounting to €93.50 million. Market Cap: €48.49M ATEME, with a market cap of €48.49 million, is facing challenges as it remains unprofitable with increasing losses over the past five years. Despite generating €93.50 million in sales last year, its net loss widened to €5.38 million from the previous year. The company's high net debt to equity ratio of 68.4% raises concerns about financial leverage, though it has sufficient cash runway for over three years if maintaining its current free cash flow level. Recent developments include showcasing cloud-based broadcast technology at NAB 2025, highlighting potential efficiencies and cost savings for broadcasters transitioning to ATSC 3.0 standards. Take a closer look at ATEME's potential here in our financial health report. Learn about ATEME's future growth trajectory here. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Medivir AB (publ) is a pharmaceutical company that develops and commercializes cancer treatments in the Nordic region, Europe, and internationally, with a market cap of SEK207.51 million. Operations: The company generates revenue of SEK3.58 million from its pharmaceuticals segment. Market Cap: SEK207.51M Medivir AB, with a market cap of SEK207.51 million, is navigating the challenges typical of pre-revenue biotech firms. The company reported minimal revenue of SEK0.8 million for Q1 2025 and continues to be unprofitable, with a net loss narrowing to SEK13.3 million from the previous year. Despite financial hurdles, Medivir has made significant strides in its oncology pipeline, securing a European patent for its fostroxacitabine bralpamide combination therapy until 2041 and presenting promising phase 1b/2a trial results for advanced liver cancer treatment at an international summit, indicating potential future growth opportunities in this niche market. Get an in-depth perspective on Medivir's performance by reading our balance sheet health report here. Examine Medivir's earnings growth report to understand how analysts expect it to perform. Dive into all 449 of the European Penny Stocks we have identified here. Ready For A Different Approach? Uncover 16 companies that survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BIT:DGT ENXTPA:ATEME and OM:MVIR. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
